JP2007533728A5 - - Google Patents

Download PDF

Info

Publication number
JP2007533728A5
JP2007533728A5 JP2007509007A JP2007509007A JP2007533728A5 JP 2007533728 A5 JP2007533728 A5 JP 2007533728A5 JP 2007509007 A JP2007509007 A JP 2007509007A JP 2007509007 A JP2007509007 A JP 2007509007A JP 2007533728 A5 JP2007533728 A5 JP 2007533728A5
Authority
JP
Japan
Prior art keywords
lactalbumin
use according
biologically active
variant
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007509007A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533728A (ja
Filing date
Publication date
Priority claimed from GBGB0408752.4A external-priority patent/GB0408752D0/en
Application filed filed Critical
Publication of JP2007533728A publication Critical patent/JP2007533728A/ja
Publication of JP2007533728A5 publication Critical patent/JP2007533728A5/ja
Abandoned legal-status Critical Current

Links

JP2007509007A 2004-04-20 2005-04-20 ウイルス感染を治療するためのhamlet(腫瘍細胞に致死的なヒトアルファ−ラクトアルブミン)の使用 Abandoned JP2007533728A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0408752.4A GB0408752D0 (en) 2004-04-20 2004-04-20 Therapeutic treatment
PCT/IB2005/001255 WO2005102382A1 (en) 2004-04-20 2005-04-20 Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections

Publications (2)

Publication Number Publication Date
JP2007533728A JP2007533728A (ja) 2007-11-22
JP2007533728A5 true JP2007533728A5 (cg-RX-API-DMAC10.html) 2008-06-05

Family

ID=32344046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007509007A Abandoned JP2007533728A (ja) 2004-04-20 2005-04-20 ウイルス感染を治療するためのhamlet(腫瘍細胞に致死的なヒトアルファ−ラクトアルブミン)の使用

Country Status (6)

Country Link
US (1) US20070232550A1 (cg-RX-API-DMAC10.html)
EP (1) EP1765383A1 (cg-RX-API-DMAC10.html)
JP (1) JP2007533728A (cg-RX-API-DMAC10.html)
CN (1) CN1980688A (cg-RX-API-DMAC10.html)
GB (1) GB0408752D0 (cg-RX-API-DMAC10.html)
WO (1) WO2005102382A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113855787A (zh) * 2020-06-30 2021-12-31 北京大学 乳清蛋白作为冠状病毒广谱抑制剂的用途
CN120860183A (zh) * 2021-08-31 2025-10-31 合生元(广州)健康产品有限公司 用于抑制冠状病毒的组合物及其应用
CN113827707B (zh) * 2021-09-30 2023-12-05 北京大学 a-乳白蛋白在抑制冠状病毒中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment

Similar Documents

Publication Publication Date Title
JP2007526248A5 (cg-RX-API-DMAC10.html)
BR0114471A (pt) Composições para a saúde dos ossos, derivadas do leite
RU2008103827A (ru) Детское питание с гидролизованными белками
HRP20161353T1 (hr) Rekombinantni rsv antigeni
JP2010536714A5 (cg-RX-API-DMAC10.html)
WO2000049040A3 (en) Antimicrobial/endotoxin neutralizing polypeptide
JP2005519914A5 (cg-RX-API-DMAC10.html)
JP2020536096A5 (cg-RX-API-DMAC10.html)
JP2004525962A5 (cg-RX-API-DMAC10.html)
JP2005530703A5 (cg-RX-API-DMAC10.html)
JP2006500321A5 (cg-RX-API-DMAC10.html)
JP2003522782A5 (cg-RX-API-DMAC10.html)
JP2007524708A5 (cg-RX-API-DMAC10.html)
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
JP2010053141A5 (cg-RX-API-DMAC10.html)
CN100415768C (zh) 乳清蛋白酶法生产血管紧张素转化酶(ace)抑制肽的方法
EP1506233B1 (en) Active complex of alpha-lactalbumin (hamlet) and cofactor
JP2007533728A (ja) ウイルス感染を治療するためのhamlet(腫瘍細胞に致死的なヒトアルファ−ラクトアルブミン)の使用
JP2021525083A5 (cg-RX-API-DMAC10.html)
JP2006510360A5 (cg-RX-API-DMAC10.html)
KR20110089705A (ko) 유청단백질의 Protamex 효소 가수분해물 및 그 제조방법
TW200612975A (en) Permucosal composition and method of improving permucosal absorption
CN309821374S (zh) 吊灯(2025-26)
CN309930538S (zh) 吊灯灯体(zps2110047)
CN309458569S (zh) 吊灯灯体(8018牛奶灯)